Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor (Q48238155)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2003

Language	Label	Description	Also known as
English	Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor	scientific article published in July 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

1 reference

based on heuristic

inferred from title

author name string

Syuntaro Takasu

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Toshitada Takahashi

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Sho Okamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Noboru Oriuchi

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Norihisa Nakayashiki

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Kenta Okamoto

6

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Hideki Muramatsu

7

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Takeshi Hayashi

8

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Norimoto Nakahara

9

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Masaaki Mizuno

10

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Toshihiko Wakabayashi

11

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Tetsuya Higuchi

12

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Keigo Endo

13

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Kenichi Kozaki

14

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Osamu Miyaishi

15

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Shinsuke Saga

16

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Ryuzo Ueda

17

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Jun Yoshida

18

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Kazuhiro Yoshikawa

19

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

63

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

247-256

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody therapy of human gliomas: current status and future approaches

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scintigraphic detection of xenografted renal tumor by anti-renal cancer monoclonal antibody radiolabeled with technetium-99m

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iodine125 labeled anti-epidermal growth factor receptor-425 in the treatment of malignant astrocytomas. A pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunodiagnosis of tumors in vivo using radiolabeled monoclonal antibody A2B5

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction-mediated technetium-99m labeling of monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific targeting of a mutant, activated egf receptor found in glioblastoma using a monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new antibody recognizing the vIII mutation of human epidermal growth factor receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFRvIII as a promising target for antibody-based brain tumor therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of a single-chain variable fragment antibody recognizing type III mutant epidermal growth factor receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Technetium-99m labeling of murine monoclonal antibody fragments

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structural alterations of the epidermal growth factor receptor gene in human gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies to growth factors and growth factor receptors: their diagnostic and therapeutic potential in brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12892230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1024320516341

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/12892230

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48238155&oldid=2209244679"